Epidemiology of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in Japan: Characteristics of community-associated versus healthcare-associated ESBL E. coli. Issue 2 (February 2017)

• Record Type: Journal Article
• Authors: Hayakawa, Kayoko; Nagamatsu, Maki; Mezaki, Kazuhisa; Sugiki, Yuko; Kutsuna, Satoshi; Takeshita, Nozomi; Yamamoto, Kei; Mawatari, Momoko; Fujiya, Yoshihiro; Ohmagari, Norio
• Is Part Of: Journal of infection and chemotherapy. Volume 23:Issue 2(2017:Feb.)
• Page Start: 117
• Page End: 119
• Publication Date: 2017-02
• Subjects: CTX-M -- Community-associated -- Antimicrobial resistance -- Escherichia coli; Chemotherapy -- Periodicals; Infection -- Periodicals; Communicable diseases -- Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1016/j.jiac.2016.08.010
• Languages: English
• ISSNs: 1341-321X

Abstract

Abstract: Data on community-associated extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (CA-ESBLEC) infections in Japan are scarce. We compared the clinical and microbiological epidemiology of CA-ESBLEC infections with that of healthcare-associated-ESBLEC infections among 76 patients with ESBLEC infections. We identified a high prevalence (26%) of CA-ESBLEC infections in Japan; only a small proportion (15%) of patients with CA-ESBLEC infections had recent exposure to antibiotics.